GlassScriptPhysician profile
Kimberly B Loar
NPI 1528002847
$548.30
in general payments reported to CMS, 2019-2025
15 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $54.09 · 2021: $14.52 · 2022: $86.25 · 2023: $15.08 · 2024: $75.92 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $121.36 | 2019-2025 | |
| Astellas Pharma US INC | $72.67 | 2025 | Veozah |
| Pfizer INC. | $56.41 | 2019-2020 | |
| Janssen Biotech, INC. | $49.78 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $49.05 | 2025 | Lynparza |
| Gilead Sciences, INC. | $31.48 | 2024 | |
| Baxter Healthcare | $24.96 | 2019 | |
| Eisai INC. | $24.14 | 2024 | |
| Merck Sharp & Dohme LLC | $23.19 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.09 | 2025 | Libtayo |
| Hologic Sales and Service, LLC | $16.91 | 2019 | |
| Axonics, INC. | $15.97 | 2020 | |
| Kite Pharma, INC. | $15.08 | 2023 | |
| Avion Pharmaceuticals | $14.93 | 2020 | |
| Seagen INC. | $13.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Loar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.